Table 1.
Time period | Participation in addiction treatment program required | Prenatal care requirements | Urine toxicology requirements: number of weeks without aberrant testing before deliverya | Breastfeeding eligibility guidelines and institution breastfeeding improvements |
---|---|---|---|---|
01/2006–12/2009 | Yes | None | 12 | • 2006 First Written Breastfeeding Guidelines |
01/2010–12/2012 | Yes | ≥12 weeks before delivery, no more than two missed visits | 10 | • 2010 Revised Written Breastfeeding Guidelines |
• 2010 Brochure on benefits of breastfeeding in OUD developed and distributed passively in prenatal clinic | ||||
01/2013–03/2015 | Yes | ≥12 weeks before delivery, no more than two missed visits | 10 | • 2013 NAS QI Committee formed; statewide QI collaborative started |
• 2013–14 NAS QI Committee focuses on standardization of monitoring of NAS infants and early pharmacologic treatment | ||||
• Early 2015 NAS QI Committee reviewed breastfeeding guidelines | ||||
04/2015–12/2016 | Yes | Attendance at ≥50% or ≥5 prenatal visits | 4 | • April 2015 revised breastfeeding guidelines approved |
• 04/2015 Started active face-to-face prenatal breastfeeding education | ||||
• 2015 NAS QI Committee focuses on: (1) skin-to-skin, (2) rooming-in, and (3) lactation support, after mothers are discharged, but infant still admitted. |
Aberrant toxicology test defined as any nonprescribed opioids, benzodiazepines, amphetamines, or other illicit substances.
NAS, neonatal abstinence syndrome; OUD, opioid use disorder; QI, quality improvement.